未登录

T

Tarek Ibrahim

faculty of pharmacy

H指数:25

被引数:1,710

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction Note: Nasal In-Situ Gels of Brij®-Enriched Novasomes as Optimistic Nanovesicular Carriers for Enhancing Anti-Depressant Action of Agomelatine

撤回通知：富集Brij®的新型脂质体作为增强阿戈美拉汀抗抑郁作用的鼻腔原位凝胶纳米囊泡载体

AAPS PharmSciTech

IF4

2026-07-230

OAAI

Nasal In-Situ Gels of Brij®-Enriched Novasomes as Optimistic Nanovesicular Carriers for Enhancing Anti-Depressant Action of Agomelatine

AAPS PHARMSCITECH

IF4

2025-04-170

OA

Fabrication and Optimization of a Silodosin In Situ-Forming PLGA Implants for the Treatment of Benign Prostatic Hyperplasia: In Vitro and In Vivo Study

IF5.5

2024-10-250

OAAI

Evaluation of Mucoadhesive Nano-Bilosomal In Situ Gels Containing Anti-Psychotic Clozapine for Treatment of Schizophrenia: In Vitro and In Vivo Studies

含抗精神病药物氯氮平的粘膜粘附纳米双体原位凝胶治疗精神分裂症的体外和体内研究

PHARMACEUTICALS

IF4.8

2024-10-210

OAAI

The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats

JOURNAL OF MICROENCAPSULATION

IF3.2

2024-09-041

PRE

Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies

用于增强鼻内药物递送的负载维拉帕米的立方体: 开发，表征，离体渗透和脑生物分布研究

AAPS PHARMSCITECH

IF4

2024-05-067

OA

AT1-AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B-Cell Depletion Without Compromising Overall Offspring Health

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2024-02-200

OAAI

The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model

BMC MICROBIOLOGY

IF4.2

2024-02-105

OAAI

The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment

IF5.5

2023-11-261

OAAI

Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box-Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route

IF5.5

2023-10-247

OAAI

Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity

IF5.3

2023-06-184

OAAI

Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control

SAUDI PHARMACEUTICAL JOURNAL

IF3.4

2023-04-018

OAAI

B2 cells contribute to hypertension and natural killer cell activation possibly via AT1-AA in response to placental ischemia

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY

IF3.4

2023-02-018

OA

Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats

IF5.5

2022-09-0512

OAAI

IL17 administration in the Absence of T cells Results in Hypertension, NK cell Activation, and Reduced Pup Weight at Birth, but No Changes in Blood Pressure or Weight at Maturation of Offspring

IF4.2

2022-05-130

PRE

Electrospun Nanofibers Revisited: An Update on the Emerging Applications in Nanomedicine

IF3.2

2022-03-0431

OAAI

Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications

PHARMACEUTICALS

IF4.8

2022-01-0721

OAAI

Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy

IF5.2

2021-10-2014

OAAI

Low Dose of IL-2 Normalizes Hypertension and Mitochondrial Function in the RUPP Rat Model of Placental Ischemia

IF5.2

2021-10-196

OAAI

IL-17 Causes Hypertension, Reduced Fetal Weight And Natural Killer Cell Activation In The Absence Of T Cells

IF8.2

2021-09-010

PRE